Skip to main content
Cell Proliferation logoLink to Cell Proliferation
. 2018 Aug 9;51(6):e12503. doi: 10.1111/cpr.12503

Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway

Wenjuan Ma 1, Xueping Xie 1, Xiaoru Shao 1, Yuxin Zhang 1, Chenchen Mao 1, Yuxi Zhan 1, Dan Zhao 1, Mengting Liu 1, Qianshun Li 1, Yunfeng Lin 1,
PMCID: PMC6528883  PMID: 30091500

Abstract

Objectives

The main purpose of current study was to explore the effects of tetrahedral DNA nanostructures (TDNs) on neuroectodermal (NE‐4C) stem cells migration and unveil the potential mechanisms.

Materials and methods

The successfully self‐assembled TDNs were also determined by dynamic light scattering (DLS). A bidirectional wound‐healing assay and transwell chamber assay were employed to test the migrating behaviour of NE‐4C stem cells cultured under different conditions.

Results

Through an in vitro study, we found that stem cells could internalize TDNs quickly, and the cells’ parallel and vertical migration was promoted effectively. Besides, the effects of TDNs were found being exerted by upregulating the gene and protein expression levels of RhoA, Rock2 and Vinculin, indicating that the RHOA/ROCK2 pathway was activated by the TDNs during the cell migration.

Conclusions

In conclusion, TDNs could enter NSCs without the aid of other transfection reagents in large amounts, whereas only small amounts of ssDNA could enter the cells. TDNs taken up by NSCs activated the RHOA/ROCK2 signalling pathway, which had effects on the relevant genes and proteins expression, eventually promoting the migration of NE‐4C stem cells. These findings suggested that TDNs have great potential in application for the repair and regeneration of neural tissue.

1. INTRODUCTION

Neural stem cells (NSCs) orchestrate embryonic nervous system development and can equilibrate and repair injured nerve tissue when needed.1, 2, 3, 4, 5 In the developing nervous system, pluripotent embryonic NSCs can proliferate, migrate and differentiate to form each component of the whole system.5, 6, 7, 8, 9 In recent years, because of their role in neural repair and regeneration, transplantation of NSCs has become increasingly attractive in cell transplantation for neurological diseases, such as cerebral palsy, spinal cord injury and motor neuron disease.1, 2, 3, 4, 5, 9, 10, 11 While the proliferation, migration and differentiation of NSCs are promising, an effective intermediate is urgently needed to promote these biological behaviours of NSCs.10, 11, 12, 13, 14, 15, 16, 17

DNA materials have been widely investigated with the aid of DNA nanotechnology.18, 19, 20, 21, 22, 23, 24, 25, 26 DNA materials have shown potential in various biomedical fields, such as anti‐multidrug resistance and disease diagnostics/therapeutics.20, 21, 22, 23, 24, 25, 26 Different DNA nanostructures maintain various biological effects; among them, one of the most promising nanomaterials is tetrahedral DNA nanostructures (TDNs).27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 This kind of DNA material has received increased research attention because of its biological safety and simplicity of synthesis.34, 35, 36 Self‐assembled TDNs comprise 4 single‐stranded DNAs (ssDNAs) that are designed based on the principle of base pairing. Therefore, TDNs possess excellent structural stability, mechanical rigidity and modification versatility.30, 33, 38 Previous studies of TDNs have shown that different cells could internalize TDNs, and then TDNs exerted influence on the cells’ biological behaviours under certain conditions.39, 40, 41, 42, 43, 44 For instance, TNDs could maintain the chondrocyte phenotype, promote chondrocyte proliferation and accelerate dental pulp stem cells osteo/odontogenic differentiation.35, 44 Meanwhile, TDNs could be modified by aptamers to detect tumour cells and are considered as potential carriers for drug delivery to reverse tumour resistance.30, 42 In our recent work, we observed that TDNs promoted the proliferation of NSCs and accelerated the process of NSCs neuronal differentiation in vitro.41 However, whether TDNs could also exhibit effects in promoting the migration of NSCs remains unclear, and the potential underlying mechanism also remains elusive

Physiologically, cellular migration is an intricate biological behaviour which is a pivotal ingredient of biological processes, including development of embryonic, immune responses and tissue regeneration.6, 7, 8, 36, 45 Migration is also considered a vital pathological component of diseases such as metastatic cancer and chronic inflammatory diseases.46, 47, 48, 49, 50 In the nervous system, after injury, NSCs migrate to the damaged area where they secrete certain growth factors to further accelerate NSCs migration, and then differentiate into neurocytes.51 This is a key process in the repair and regeneration of nerves and their accessory cells. However, the proliferation, migration and differentiation abilities of NSCs are poor, making it hard to repair and regenerate injured neural tissue.10, 11, 52, 53 Therefore, studies exploring biomaterials that could promote the migration of NSCs safely and effectively will be of great significance in searching cures of neural system diseases. To find out whether TDNs could promote NSCs migration, together with our previous study,41 might provide systematic evidence of effects of TDNs on the biological behaviour of NSCs in vitro and of the possible use in future nerve tissue repair and regeneration.

In this study, using in vitro experiments, we investigated the performance of TDNs in the migration of neuroectodermal (NE‐4C) stem cells; then, the potential mechanism was also explored. NE‐4C stem cells are an in vitro model of NSCs and possess the abilities of proliferation and differentiation into the neuronal lineage. We hypothesized that TDNs could facilitate the migration of NSCs safely and effectively, thus representing a promising material for nerve tissue repair and regeneration in curing neurological diseases.

2. MATERIALS AND METHODS

2.1. Cell culture

NE‐4C stem cells of mouse were bought from ATCC (CRL‐2925, VA, USA). Dulbecco's modified Eagle's medium (DMEM, Gibco, Grand Island, USA) was used to culture the cells which containing 1% (v/v) Penicillin‐streptomycin solution (Gibco, Grand Island, USA), and 10% (v/v) foetal bovine serum (FBS, Corning, New York, USA). The cells were cultivated in a humidified incubator at the temperature of 37°C, 5% CO2 in the atmosphere. The growth medium was changed thrice every week.

2.2. TDNs synthesis and characterization

The same concentrations of each ssDNAs (TaKaRa, Ostu, Japan) were added to TM buffer (Tris‐HCl = 10 mmol/L; MgCl2 = 50 mmol/L, pH = 8.0; Bio‐Rad, Hercules, USA). The mixtures were heated for 10 minutes at 95°C and then cooled at 4°C for 40 minutes. TDNs’ concentration used in our experiment is 250 nmol/L, which was proven to be the optimal concentration in our previous studies.40, 41, 43

To ensure the synthesis of self‐assembled TDNs, we tested the size of the TDNs and the 4 ssDNA by Polyacrylamide gel electrophoresis (8% PAGE, Beyotime, Nanjing, China). The successfully self‐assembled TDNs were also determined by dynamic light scattering (DLS) in ddH2O at 250 nmol/L using a ZETAPals analyser (Brookhaven Instruments, Holtsville, NY, USA).

2.3. Cellular uptake of TDNs

To ensure that the cells could take in TDNs, we treated the cells with TDNs or ssDNA, which were both modified with Cyanine‐5 (Cy5). First, cells were seeded onto confocal dishes. The growth medium was changed to a medium with Cy5‐TDNs or Cy5‐ssDNA for 12 hours. Then, we washed the cell samples using phosphate‐buffered saline (PBS, Gibco, Grand Island, USA) for 3 times, and fixed them with paraformaldehyde solution (4% w/v, Boster, Wuhan, China). After all samples were rinsed 3 times, FITC‐labelled phalloidin (Sigma, St Louis, USA), together with DAPI (Sigma, St Louis, USA), was applied to stain each of cytoskeleton and nucleus. All samples were washed by PBS 3 times before being imaged under a confocal laser microscope (Nikon N‐SIM, Japan).

Cellular uptake of TDNs was also tested by flow cytometry. Briefly, cells were firstly plated to 6‐well plate (2 × 105/well); then, we changed the medium with that containing Cy5‐TDNs or Cy5‐ssDNA. After 12 hours, the cells were collected and tested by the flow cytometer (FC500 Beckman, Brea, USA).

2.4. Parallel cell migration (wound healing assay)

A bidirectional wound‐healing assay was employed to test the migrating behaviour of NE‐4C stem cells cultured under different conditions. Briefly, cells were first plated to 6‐well plates and then incubated at 5% CO2 and 37°C. Sterilized pipette tips were applied to form a bidirectional wound by scratching the single‐layer cells. PBS was applied to wash the cell debris away. Cells were treated with medium without FBS (the control groups: without TDNs) and the same medium containing TDNs (the experimental groups: 250 nmol/L TDNs). Wound closure of cells was imaged after incubation for 0, 12 and 24 hours.

2.5. Vertical cell migration (Transwell chamber assay)

Transwell insert (pore diameter: 8 μm; Corning) was applied to analyse the vertical cell migration.54 Transwell inserts were attached to 6‐well culture plate, and cells (1 × 105/well) were seeded on the upper half of the insets. The growth medium was changed to the medium without FBS (the control groups: without TDNs; the experimental groups: 250 nmol/L TDNs). After incubated for 24 hours, cells in the upper insets were fixed in paraformaldehyde, staining with DAPI. The amount of cells presented in the lower part was determined by manual counting, and the results of migration were presented by using the mean number of cells.

2.6. Semi‐quantitative PCR and quantitative PCR

Total RNA of cells treating with or without TDNs was extracted by an RNeasy Plus Mini Kit and treated with a genomic DNA eliminator. The RNA samples were reverse transcribed into cDNA using a synthesis kit (TaKaRa, Ostu, Japan). The mRNAs (Table 1) expressions of each group were normalized to the housekeeper genes of glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) and evaluated. Semi‐quantitative PCR was conducted with a PCR kit (Mbi, TaKaRa, Ostu, Japan), while quantitative PCR (qPCR) was conducted using SYBR Green II PCR master mix (TaKaRa, Ostu, Japan) and a Bio‐Rad CFX96TM thermal cycler (Bio‐Rad). The semi‐quantitative PCR procedure included a 30‐second denaturation at 94°C, 30‐second annealing cycle at 55‐65°C and a 30‐second elongation cycle at 72°C, for 28‐35 amplification cycles. Products were detected by 2% agarose gel electrophoresis in TAE buffer and stained using Gel‐Red (Sigma, St Louis, USA). The procedure for qPCR comprised 2 minutes of denaturation at 95°C, 5 seconds annealing at 95°C and 30 seconds elongation at 60°C for 40 cycles.

Table 1.

The primer sequences of relevant genes designed for qPCR

mRNA Primer pairs Product length (bp)
GAPDH Forward 5′‐AGAGGGATGCTGCCCTTACC‐3′
Reverse 5′‐ATCCGTTCACACCGACCTTC‐3′
109
RhoA Forward 5′‐GCTCTTTTATAGCCCCGGTGT‐3′
Reverse 5′‐CCACGATTGCTCAAGAACGC‐3′
116
Rock2 Forward 5′‐CTGTGATCCCAAGGGAAGGCT‐3′
Reverse 5′‐ACTGACAGCAGCAGTATGCC‐3′
147
Vinculin Forward 5′‐TGGTCTAGCAAGGGCAATGA‐3′
Reverse 5′‐CTCGTCACCTCATCAGAGGC‐3′
155

2.7. Western blotting

After 24 hours treated with 250 nmol/L TDNs or vehicle control, NE‐4C stem cells were washed with PBS after thrice loop operations, and a Whole Cell Lysis Assay (KeyGEN Institute of Biotechnology, Jiangsu, China) was applied to harvest all the proteins. The protein samples and 5× loading buffer (Beyotime, Nanjing, China) were mixed together at a ratio of 4:1, and then the mixed samples were heated for 3 minutes at 100°C. The mixed samples were subjected to SDS‐PAGE (Beyotime, Nanjing, China) at different gel concentrations to separate the proteins, and then transferred to Polyvinylidene fluoride membranes (PVDF, TaKaRa, Ostu, Japan). After incubating with 5% skim milk powder solution for 1 hour, all membranes were incubated with primary antibodies (anti‐GAPDH, anti‐RhoA, anti‐Rock2, and anti‐Vinculin; Abcam, Cambridge, U.K) overnight at 4°C. All membranes were rinsed with TBST thrice next day and incubated with secondary antibodies for 1 hour. All membranes were washed thrice with TBST and tested by an enhanced chemiluminescence detection system (Bio‐Rad).

2.8. Immunofluorescence staining

Cells in confocal dishes treated with or without TNDs for 24 hours were fixed in paraformaldehyde solution. All samples were then treated with 0.5% Triton X‐100 and then blocked with 5% sheep serum. The samples were treated overnight with primary antibodies solution (anti‐RhoA, anti‐Rock2 and anti‐Vinculin; Abcam, Cambridge, U.K) at 4°C. The next day, the cells were incubated with secondary antibodies for 1 hour. The cytoskeleton was stained with phalloidine at 37°C for 1 hour and the nuclei with DAPI for 10 minutes. Every step in this experiment was followed by 3 washes with PBS for 10 minutes. Finally, a confocal laser microscope (Nikon N‐SIM, Japan) was applied to capture images.

2.9. Statistical analysis

SPSS (version 23.0) was applied for data analysis. Intergroup differences were compared using analysis of variance (ANOVA) and t test, and < .05 indicated that the test results were statistically significant. All experiments and analyses were conducted in triplicate and replicated more than 3 times.

3. RESULTS

3.1. TDN characterizations

TDNs comprised 4 different ssDNA (Figure 1A), and each ssDNA was designed with a specific sequence based on the base complementation pairing rules (Table 2). To evaluate the synthesis and characterization of the TDNs, 8% PAGE was performed to assess the size and size distribution of the TDNs. Figure 1B shows that the TDNs were successfully synthesized. Figure 1C shows that the average size of TDNs was 16.801 ± 0.237 nm. These results indicated that the TDNs were successfully constructed.

Figure 1.

Figure 1

Successful synthesis and characterization of TDNs. A, Schematic diagram of TDNs. B, Confirmation of the successful synthesis of TDNs by 8% PAGE (polyacrylamide gel electrophoresis; TDNs: red circle). Lane 1 is S1. Lane 2 is S2. Lane 3 is S3. Lane 4 is S4. Lane 5 is S1+S2. Lane 6 is S1+S2+S3. Lane 7 is S1+S2+S3+S4, representing the successful synthesis of TDNs. C, Typical size distribution graph of TDN

Table 2.

Base sequence of each ss DNA

ss DAN Base sequence Direction
Cy5‐S1 Cy5‐ATTTATCACCCGCCATAGTAGACGTATCACCAGGCAGTTGAGACGAACATTCCTAAGTCTGAA 5′→3′
S1 ATTTATCACCCGCCATAGTAGACGTATCACCAGGCAGTTGAGACGAACATTCCTAAGTCTGAA 5′→3′
S2 ACATGCGAGGGTCCAATACCGACGATTACAGCTTGCTACACGATTCAGACTTAGGAATGTTCG 5′→3′
S3 ACTACTATGGCGGGTGATAAAACGTGTAGCAAGCTGTAATCGACGGGAAGAGCATGCCCATCC 5′→3′
S4 ACGGTATTGGACCCTCGCATGACTCAACTGCCTGGTGATACGAGGATGGGCATGCTCTTCCCG 5′→3′

3.2. Cellular uptake of TDNs

To ensure that NE‐4C stem cells could take in abundant TDNs, but not ssDNA, fluorescence staining and flow cytometry were used to track TDNs and ssDNA. As shown in Figure 2A,B, the fluorescence signal of Cy5 in the cells treated with Cy5‐loaded TDNs was stronger than that from cells treated with Cy5‐loaded ssDNA. Flow cytometry showed that more cells took in Cy5‐loaded TDNs than Cy5‐loaded ssDNA (Figure 2C‐D). These results indicated that the cells could take in TDNs specifically, which is a prerequisite of TDNs to affect cellular biological behaviour.

Figure 2.

Figure 2

Cellular uptake of TDNs. A, Interaction of NE‐4C stem cells with 250 nmol/L Cy5‐ssDNA (the control group) or 250 nM Cy5‐TDNs for 12 h (Cy5: red, cytoskeleton: green, nucleus: blue). Scale bars are 25 μm. B, Semi‐quantitative analysis of fluorescence of Cy5‐ssDNA and Cy5‐TDNs. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. C, After treatment with 250 nmol/L Cy5‐ssDNA or 250 nmol/L Cy5‐TDNs for 12 h, flow cytometry examination and the analysis of cellular uptake of Cy5‐ssDNA and Cy5‐TDNs (negative control: treated with nothing; positive control: treated with Cy5‐ssDNA; TDNs: treated with Cy5‐TDNs). D, Semi‐quantitative analysis of the cellular uptake in flow cytometry. Data are presented as mean ± SD (n = 4). Statistical analysis: **< .01, ***< .001

3.3. Changes in NE‐4C stem cell migration

To observe TDNs’ actions of horizontal migration on cells, we used 250 nmol/L TDNs to treat cells and analysed the migration by a wound‐healing assay, which has been applied to detect the cell migration in vitro widely. Cells migrated towards the wound areas for 24 hours, and the control group cells migrated markedly slower than the groups cells treated with 250 nmol/L TDNs (Figure 3A). Statistical analysis of the area of wound healing showed that NE‐4C stem cells migration was promoted significantly after treatment with TDNs (Figure 3B).

Figure 3.

Figure 3

A, Facilitated effects of TDNs on NE‐4C stem cells horizontal migration tested by a bidirectional wound‐healing assay at 0, 12 and 24 h. B, Histogram representation of the percentage of NE‐4C stem cells migration area at 0, 12 and 24 h on treatment without (the control group) or with TDNs. Data are presented as mean ± SD (n = 4). Statistical analysis: *< .05, ***< .001

To further confirm that TDNs could affect cell vertical migration, Transwell chamber assay was used. According to Figure 4A,B, the stem cells were plated onto the upper chamber of Transwell and treated with or without 250 nmol/L TDNs for 24 hours. Compared with the control groups, more cells of the experimental groups incubated with 250 nmol/L TDNs, migrated onto the lower surface of the Transwell. Moreover, the quantitative analysis shown in Figure 4C indicated that TDNs could enhance the migration of NE‐4C stem cells significantly. These results showed that TDNs could facilitate the stem cell migration, which is a prerequisite for the regeneration of the injured nervous system.

Figure 4.

Figure 4

A, Schematic diagram of the vertical cell migration tested by Transwell chamber assay. B, Fluorescence images showing the facilitated effects of TDNs on NE‐4C stem cell migration. The transmigrated NE‐4C stem cells’ nuclei were stained with DAPI (nucleus: blue). Scale bars are 100 μm. C, Cell number of transmigrated NE‐4C stem cells was presented by histogram. Data are presented as mean ± SD (n = 3). Statistical analysis: ***< .001

3.4. TDNs promote cell migration via the RHOA/ROCK2 pathway

Previous studies demonstrated that the RHOA/ROCK2 pathway is closely related to cell migration; therefore, changes in the expressing levels of ras homologue family member A (RhoA), rho associated coiled‐coil containing protein kinase 2 (Rock2) and Vinculin were tested in this study. From the results of semi‐quantitative PCR (Figures 5A‐B, 6A‐B, and 7A‐B) and quantitative PCR (Figures 5C, 6C and 7C), the expressions of RhoA, Rock2 and Vinculin in cells with the treatment of TDNs for 24 hours were activated by comparison with the control group.

Figure 5.

Figure 5

A, Semi‐quantitative PCR of RhoA upon exposure to 250 nmol/L TDNs for 24 h. B, Semi‐quantitative analysis of semi‐quantitative PCR of about RhoA gene expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. C, Quantitative PCR of RhoA upon exposure to 250 nmol/L TDNs for 24 h. Data are presented as mean ± SD (n = 4). Statistical analysis: *< .05. D, Western blotting analysis of RhoA protein expression level after treatment with 250 nmol/L TDNs for 24 h. E, Semi‐quantitative analysis of western blotting about RhoA protein expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. F, After treated with 250 nmol/L TDNs for 24 h, RhoA showed higher expression level in cells. Immunofluorescent images of cells treated with or without TDNs (RhoA: red, cytoskeleton: green, nucleus: blue). Scale bars are 25 μm. G, Semi‐quantitative analysis of average optical density of Figure 5F. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001

Figure 6.

Figure 6

A, Semi‐quantitative PCR of Rock2 upon exposure to 250 nmol/L TDNs for 24 h. B, Semi‐quantitative analysis of semi‐quantitative PCR of about Rock2 gene expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: **< .01. C, Quantitative PCR of Rock2 upon exposure to 250 nmol/L TDNs for 24 h. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. D, Western blotting analysis of Rock2 protein expression level after treatment with 250 nmol/L TDNs for 24 h. E, Semi‐quantitative analysis of western blotting about Rock2 protein expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. F, After treated with 250 nmol/L TDNs for 24 h, Rock2 showed higher expression level in cells. Immunofluorescent images of cells treated with or without TDNs (Rock2: red, cytoskeleton: green, nucleus: blue). Scale bars are 25 μm. G, Semi‐quantitative analysis of average optical density of Figure 6F. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001

Figure 7.

Figure 7

A, Semi‐quantitative PCR of Vinculin upon exposure to 250 nmol/L TDNs for 24 h. B, Semi‐quantitative analysis of semi‐quantitative PCR of about Vinculin gene expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: **< .01. C, Quantitative PCR of Vinculin upon exposure to 250 nmol/L TDNs for 24 h. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. D, Western blotting analysis of Vinculin protein expression level after treatment with 250 nmol/L TDNs for 24 h. E, Semi‐quantitative analysis of western blotting about Vinculin protein expression level. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001. F, After treated with 250 nmol/L TDNs for 24 h, Vinculin showed higher expression level in cells. Immunofluorescent images of cells treated with or without TDNs (Vinculin: red, cytoskeleton: green, nucleus: blue). Scale bars are 25 μm. G, Semi‐quantitative analysis of average optical density of Figure 7F. Data are presented as mean ± SD (n = 4). Statistical analysis: ***< .001

To further explore the mechanism by which TDNs activate the RHOA/ROCK2 pathway, we used both western blotting and immunofluorescence staining to analyse the protein levels of RhoA, Rock2 and Vinculin. From the results of western blotting, the group with TDNs had higher levels of RhoA, Rock2 and Vinculin than the control group (Figures 5D‐E, 6D‐E and 7D‐E); meanwhile, the immunofluorescence staining intensities of the 3 proteins in cells treated with TDNs were much stronger than those in the cells of the control group (Figures 5F,G, 6F,G and 7F,G). The gene expression and protein analysis results were consistent, thus indicated that TDNs could accelerate cells migration by upregulating RHOA/ROCK2 signalling pathway (Figure 8).

Figure 8.

Figure 8

Schematic diagram showing the underlying mechanism of TDNs promoted the NE‐4C stem cells migration via activating RHOA/ROCK2 pathway

4. DISCUSSION

NSC transplantation is an emerging therapy for various neurological and neuro‐traumatic diseases with great potential, due to its role in nervous tissue repair and regeneration.1, 2, 3, 4, 5, 9, 55, 56, 57 However, some challenges remain to be addressed before NSC transplantation could be eventually used in clinical application.12, 13, 14, 15, 16, 17 One of the biggest challenges is that transplanted NSCs cannot self‐renewal, migrate or differentiate with high efficiency.10, 11, 52, 53 In previous studies, when NSCs were transplanted into a specific nervous tissue site to promote NSCs proliferation, migration and differentiation, many biological agents were tested through co‐transplantation with NSCs, such as scaffolds, neurotrophic growth factors and neurotrophic drugs.12, 13, 14, 15, 16, 17, 51 However, they all have shown either low efficacy or resistance to degradation.12, 13, 14, 15, 16, 17 Thus, there still lack an effective biomaterial which could promote NSCs proliferation, migration and differentiation, and new types of materials or drugs with lower toxicity, lower cost and better biosecurity are urgently required.

Recently, TDNs, a tough and flexible nanomaterial, have been shown with great potential in different biological functions, such as cell proliferation, differentiation and anti‐inflammation.39, 40, 41, 42, 43, 44, 58 Recently, we demonstrated that TDNs could enhance the proliferation and differentiation of NSCs in vitro.41 In present study, we further investigated the effects of TDNs and found that they could promote NSCs migration via upregulating the related genes and proteins of RHOA/ROCK2 signalling pathway in vitro.59 While the migration of NSCs from the transplantation site to the injured areas play a critical part in neurogenesis,6, 7, 8, 60 findings of current study, together with those from the recent one,41 systematically showed that TDNs could enhance NSCs proliferation, migration and differentiation. Despite the lack of animal experimental data in our study, we strongly believe that TDNs possess potential uses for nervous tissue repair and regeneration of cells in neurological diseases. Therefore, further studies in vivo are necessary.

In addition to their innate biological functions, TDNs are ideal biological carriers. According to previous studies, TDNs could be modified by aptamers to detect tumours and could deliver drugs to treat tumours.29, 30, 42 Therefore, we postulated that TDNs could serve a dual purpose: on one hand, TDNs could help NSCs proliferate, migrate and differentiate in nervous tissue regeneration; on the other hand, TDNs might act as drug carriers for medicines that could increase neurogenesis, such as neurotrophic growth factors. Taken together, the data in our studies have shown that treatment with TDNs would enhance neurological recovery by increasing neurogenesis including cell proliferation, migration, and differentiation. Thus, TDNs have the potential to be further researched and developed as a therapeutic for neuroregeneration, and a kind of carries for deliver drugs to treating neurological diseases.

CONFLICT OF INTEREST

All authors declare no competing financial interest.

ACKNOWLEDGEMENTS

We acknowledge the financial support from the National Natural Science Foundation of China (81671031, 814702721) and Sichuan Province Youth Science and Technology Innovation Team (2014TD0001). We would be grateful to Doctor Chenghui Li (Analytical & Testing Center, Sichuan University) for her help of taking laser scanning confocal images.

Ma W, Xie X, Shao X, et al. Tetrahedral DNA nanostructures facilitate neural stem cell migration via activating RHOA/ROCK2 signalling pathway. Cell Prolif. 2018;51:e12503 10.1111/cpr.12503

REFERENCES

  • 1. Hoffman RM. Nestin‐expressing hair follicle‐accessible pluripotent stem cells for nerve and spinal cord repair. Cells Tissues Organs. 2014;200:42‐47. [DOI] [PubMed] [Google Scholar]
  • 2. Kim SU, Lee HJ, Kim YB. Neural stem cell‐based treatment for neurodegenerative diseases. Neuropathology. 2013;33:491‐504. [DOI] [PubMed] [Google Scholar]
  • 3. Nabetani M, Shintaku H, Hamazaki T. Future perspectives of cell therapy for neonatal hypoxic‐ischemic encephalopathy. Pediatr Res. 2017;83:356‐363. [DOI] [PubMed] [Google Scholar]
  • 4. Niimi Y, Levison SW. Pediatric brain repair from endogenous neural stem cells of the subventricular zone. Pediatr Res. 2017;83:385‐396. [DOI] [PubMed] [Google Scholar]
  • 5. Yue Y, Yang X, Zhang L, et al. Low‐intensity pulsed ultrasound upregulates pro‐myelination indicators of Schwann cells enhanced by co‐culture with adipose‐derived stem cells. Cell Prolif. 2016;49:720‐728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Cui C, Wang P, Cui N, Song S, Liang H, Ji A. Stichopus japonicus Polysaccharide, Fucoidan, or Heparin Enhanced the SDF‐1alpha/CXCR4 Axis and Promoted NSC Migration via Activation of the PI3K/Akt/FOXO3a Signaling Pathway. Cell Mol Neurobiol. 2016;36:1311‐1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Jinnou H, Sawada M, Kawase K, et al. Radial Glial fibers promote neuronal migration and functional recovery after neonatal brain injury. Cell Stem Cell. 2018;22:e129. [DOI] [PubMed] [Google Scholar]
  • 8. Saha B, Peron S, Murray K, Jaber M, Gaillard A. Cortical lesion stimulates adult subventricular zone neural progenitor cell proliferation and migration to the site of injury. Stem cell research. 2013;11:965‐977. [DOI] [PubMed] [Google Scholar]
  • 9. Wei Y, Gong K, Zheng Z, et al. Schwann‐like cell differentiation of rat adipose‐derived stem cells by indirect co‐culture with Schwann cells in vitro. Cell Prolif. 2010;43:606‐616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Giusto E, Donega M, Cossetti C, Pluchino S. Neuro‐immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol. 2014;260:19‐32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Lang AE, Obeso JA. Stem cell therapy for Parkinson's disease. Ann Neurol. 2012;71:283. author reply 284. [DOI] [PubMed] [Google Scholar]
  • 12. Busl KM, Greer DM. Hypoxic‐ischemic brain injury: pathophysiology, neuropathology and mechanisms. NeuroRehabilitation. 2010;26:5‐13. [DOI] [PubMed] [Google Scholar]
  • 13. Li R, Liu Z, Pan Y, Chen L, Zhang Z, Lu L. Peripheral nerve injuries treatment: a systematic review. Cell Biochem Biophys. 2014;68:449‐454. [DOI] [PubMed] [Google Scholar]
  • 14. Chen Y, Huang X, Chen W, Wang N, Li L. Tenuigenin promotes proliferation and differentiation of hippocampal neural stem cells. Neurochem Res. 2012;37:771‐777. [DOI] [PubMed] [Google Scholar]
  • 15. Liang Z, Shi F, Wang Y, et al. Neuroprotective effects of tenuigenin in a SH‐SY5Y cell model with 6‐OHDA‐induced injury. Neurosci Lett. 2011;497:104‐109. [DOI] [PubMed] [Google Scholar]
  • 16. Lim ST, Airavaara M, Harvey BK. Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS. Pharmacol Res. 2010;61:14‐26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Shirosaki Y, Hayakawa S, Osaka A, et al. Challenges for nerve repair using chitosan‐siloxane hybrid porous scaffolds. Biomed Res Int. 2014;2014:153808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wong CT, Ahmad E, Li H, Crawford DA. Prostaglandin E2 alters Wnt‐dependent migration and proliferation in neuroectodermal stem cells: implications for autism spectrum disorders. Cell Commun Signal. 2014;12:19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Wong CT, Ussyshkin N, Ahmad E, Rai‐Bhogal R, Li H, Crawford DA. Prostaglandin E2 promotes neural proliferation and differentiation and regulates Wnt target gene expression. J Neurosci Res. 2016;94:759‐775. [DOI] [PubMed] [Google Scholar]
  • 20. Li C, Faulkner‐Jones A, Dun AR, et al. Rapid formation of a supramolecular polypeptide‐DNA hydrogel for in situ three‐dimensional multilayer bioprinting. Angew Chem Int Ed Engl. 2015;54:3957‐3961. [DOI] [PubMed] [Google Scholar]
  • 21. Zhang Q, Jiang Q, Li N, et al. DNA origami as an in vivo drug delivery vehicle for cancer therapy. ACS Nano. 2014;8:6633‐6643. [DOI] [PubMed] [Google Scholar]
  • 22. Chao J, Liu HJ, Su S, Wang LH, Huang W, Fan CH. Structural DNA nanotechnology for intelligent drug delivery. Small. 2014;10:4626‐4635. [DOI] [PubMed] [Google Scholar]
  • 23. Chen F, Bai M, Cao K, et al. Programming enzyme‐initiated autonomous DNAzyme nanodevices in living cells. ACS Nano. 2017;11:11908‐11914. [DOI] [PubMed] [Google Scholar]
  • 24. Lin M, Wang J, Zhou G, et al. Programmable engineering of a biosensing interface with tetrahedral DNA nanostructures for ultrasensitive DNA detection. Angew Chem Int Ed Engl. 2015;54:2151‐2155. [DOI] [PubMed] [Google Scholar]
  • 25. Liu B, Song CY, Zhu D, et al. DNA‐Origami‐based assembly of anisotropic plasmonic gold nanostructures. Small. 2017;13: In press. 10.1002/smll.201603991 [DOI] [PubMed] [Google Scholar]
  • 26. Liu K, Pan D, Wen Y, et al. Identifying the genotypes of hepatitis B virus (HBV) with DNA Origami label. Small. 2017;14: In press. 10.1002/smll.201701718 [DOI] [PubMed] [Google Scholar]
  • 27. Pei H, Zuo XL, Zhu D, Huang Q, Fan CH. Functional DNA nanostructures for Theranostic applications. Acc Chem Res. 2014;47:550‐559. [DOI] [PubMed] [Google Scholar]
  • 28. Zhu D, Pei H, Yao GB, et al. A surface‐confined proton‐driven DNA pump using a dynamic 3D DNA scaffold. Adv Mater. 2016;28:6860‐6865. [DOI] [PubMed] [Google Scholar]
  • 29. Dong S, Zhao R, Zhu J, et al. Electrochemical DNA biosensor based on a tetrahedral nanostructure probe for the detection of avian Influenza A (H7N9) virus. ACS Appl Mater Interfaces. 2015;7:8834‐8842. [DOI] [PubMed] [Google Scholar]
  • 30. Fan J, Liu Y, Xu E, et al. A label‐free ultrasensitive assay of 8‐hydroxy‐2′‐deoxyguanosine in human serum and urine samples via polyaniline deposition and tetrahedral DNA nanostructure. Anal Chim Acta. 2016;946:48‐55. [DOI] [PubMed] [Google Scholar]
  • 31. Ge Z, Lin M, Wang P, et al. Hybridization chain reaction amplification of microRNA detection with a tetrahedral DNA nanostructure‐based electrochemical biosensor. Anal Chem. 2014;86:2124‐2130. [DOI] [PubMed] [Google Scholar]
  • 32. Li Q, Zhao D, Shao X, et al. Aptamer‐modified tetrahedral DNA nanostructure for tumor‐targeted drug delivery. ACS Appl Mater Interfaces. 2017;9:36695‐36701. [DOI] [PubMed] [Google Scholar]
  • 33. Li Z, Wei B, Nangreave J, et al. A replicable tetrahedral nanostructure self‐assembled from a single DNA strand. J Am Chem Soc. 2009;131:13093‐13098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Liang L, Li J, Li Q, et al. Single‐particle tracking and modulation of cell entry pathways of a tetrahedral DNA nanostructure in live cells. Angew Chem Int Ed Engl. 2014;53:7745‐7750. [DOI] [PubMed] [Google Scholar]
  • 35. Miao P, Wang B, Chen X, Li X, Tang Y. Tetrahedral DNA nanostructure‐based microRNA biosensor coupled with catalytic recycling of the analyte. ACS Appl Mater Interfaces. 2015;7:6238‐6243. [DOI] [PubMed] [Google Scholar]
  • 36. Peng Q, Shao XR, Xie J, et al. Understanding the biomedical effects of the self‐assembled tetrahedral DNA nanostructure on living cells. ACS Appl Mater Interfaces. 2016;8:12733‐12739. [DOI] [PubMed] [Google Scholar]
  • 37. Shao X, Lin S, Peng Q, et al. Tetrahedral DNA nanostructure: a potential promoter for cartilage tissue regeneration via regulating chondrocyte phenotype and proliferation. Small. 2017;13: 10.1002/smll.201602770 [DOI] [PubMed] [Google Scholar]
  • 38. Shi S, Peng Q, Shao X, et al. Self‐assembled tetrahedral DNA nanostructures promote adipose‐derived stem cell migration via lncRNA XLOC 010623 and RHOA/ROCK2 signal pathway. ACS Appl Mater Interfaces. 2016;8:19353‐19363. [DOI] [PubMed] [Google Scholar]
  • 39. Zeng D, Wang Z, Meng Z, et al. DNA tetrahedral nanostructure‐based electrochemical miRNA biosensor for simultaneous detection of multiple miRNAs in pancreatic carcinoma. ACS Appl Mater Interfaces. 2017;9:24118‐24125. [DOI] [PubMed] [Google Scholar]
  • 40. Xia Z, Wang P, Liu X, et al. Tumor‐penetrating peptide‐modified DNA tetrahedron for targeting drug delivery. Biochemistry. 2016;55:1326‐1331. [DOI] [PubMed] [Google Scholar]
  • 41. Ma W, Shao X, Zhao D, et al. Self‐assembled tetrahedral DNA nanostructures promote neural stem cell proliferation and neuronal differentiation. ACS Appl Mater Interfaces. 2018;10:7892‐7900. [DOI] [PubMed] [Google Scholar]
  • 42. Shi S, Lin S, Li Y, et al. Effects of tetrahedral DNA nanostructures on autophagy in chondrocytes. Chem Commun (Camb). 2018;54:1327‐1330. [DOI] [PubMed] [Google Scholar]
  • 43. Tian T, Li J, Xie C, et al. Targeted imaging of brain tumors with a framework nucleic acid probe. ACS Appl Mater Interfaces. 2018;10:3414‐3420. [DOI] [PubMed] [Google Scholar]
  • 44. Xie X, Shao X, Ma W, et al. Overcoming drug‐resistant lung cancer by paclitaxel loaded tetrahedral DNA nanostructures. Nanoscale. 2018;10:5457‐5465. [DOI] [PubMed] [Google Scholar]
  • 45. Zhang Q, Lin S, Shi S, et al. Anti‐inflammatory and Antioxidative effects of tetrahedral DNA nanostructures via the modulation of macrophage responses. ACS Appl Mater Interfaces. 2018;10:3421‐3430. [DOI] [PubMed] [Google Scholar]
  • 46. Zhou M, Liu NX, Shi SR, et al. Effect of tetrahedral DNA nanostructures on proliferation and osteo/odontogenic differentiation of dental pulp stem cells via activation of the notch signaling pathway. Nanomedicine. 2018;14:1227‐1236. [DOI] [PubMed] [Google Scholar]
  • 47. Shi S, Lin S, Shao X, Li Q, Tao Z, Lin Y. Modulation of chondrocyte motility by tetrahedral DNA nanostructures. Cell Prolif. 2017;50: 10.1111/cpr.12368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Ma Y, Deng F, Li P, Chen G, Tao Y, Wang H. The tumor suppressive miR‐26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Biomed Pharmacother. 2018;101:648‐655. [DOI] [PubMed] [Google Scholar]
  • 49. Miao J, Wang W, Wu S, et al. miR‐194 suppresses proliferation and migration and promotes apoptosis of Osteosarcoma cells by targeting CDH2. Cell Physiol Biochem. 2018;45:1966‐1974. [DOI] [PubMed] [Google Scholar]
  • 50. Pascal LE, Wang Y, Zhong M, et al. EAF2 and p53 Co‐Regulate STAT3 activation in prostate cancer. Neoplasia. 2018;20:351‐363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Gibbons DL, Raine T, Abeler‐Dorner L, et al. RGS1 is a key regulator of human T cell migration and a potential target for therapy in Inflammatory Bowel Disease (IBD). Immunology. 2010;131:75‐75. [Google Scholar]
  • 52. Marsal J, Agace WW. Targeting T‐cell migration in inflammatory bowel disease. J Intern Med. 2012;272:411‐429. [DOI] [PubMed] [Google Scholar]
  • 53. Nakatomi H, Kuriu T, Okabe S, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell. 2002;110:429‐441. [DOI] [PubMed] [Google Scholar]
  • 54. Cardone M. Prospects for gene therapy in inherited neurodegenerative diseases. Curr Opin Neurol. 2007;20:151‐158. [DOI] [PubMed] [Google Scholar]
  • 55. Zhang F, Duan XH, Lu LJ, et al. In vivo long‐term tracking of neural stem cells transplanted into an acute ischemic stroke model with reporter gene‐based bimodal MR and optical imaging. Cell Transplant. 2017;26:1648‐1662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Zhong J, Guo B, Xie J, et al. Crosstalk between adipose‐derived stem cells and chondrocytes: when growth factors matter. Bone research. 2016;4:15036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Li P, Tessler A, Han SS, Fischer I, Rao MS, Selzer ME. Fate of immortalized human neuronal progenitor cells transplanted in rat spinal cord. Arch Neurol. 2005;62:223‐229. [DOI] [PubMed] [Google Scholar]
  • 58. Tian TR, Zhang T, Zhou TF, Lin SY, Shi SR, Lin YF. Synthesis of an ethyleneimine/tetrahedral DNA nanostructure complex and its potential application as a multi‐functional delivery vehicle. Nanoscale. 2017;9:18402‐18412. [DOI] [PubMed] [Google Scholar]
  • 59. Zhang Q, Lin S, Zhang T, et al. Curved microstructures promote osteogenesis of mesenchymal stem cells via the RhoA/ROCK pathway. Cell Prolif. 2017;50: 10.1111/cpr.12356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Santarelli A, Mascitti M, Lo Russo L, et al. Survivin‐based treatment strategies for squamous cell carcinoma. Int J Mol Sci. 2018;19 10.3390/ijms19040971 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cell Proliferation are provided here courtesy of Wiley

RESOURCES